Protagonist Therapeutics (PTGX) Depreciation and Depletion (2020 - 2022)
Protagonist Therapeutics (PTGX) posted Depreciation and Depletion of $254000.0 for Q4 2022, down 5.93% sequentially from $270000.0 in Q3 2022, and up 8.09% YoY from $235000.0 in Q4 2021.
Protagonist Therapeutics (PTGX) Depreciation and Depletion (2020 - 2022) Analysis & Trends
Protagonist Therapeutics has reported Depreciation and Depletion for 3 years, with the latest figure at $254000.0 in Q4 2022.
- Quarterly Depreciation and Depletion rose 8.09% year-over-year to $254000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $1.0 million (up 26.94% YoY) and the FY2025 annual result came in at $1.2 million, up 37.02% from the prior year.
- Depreciation and Depletion eased to $254000.0 in Q4 2022 per PTGX's latest filing, from $270000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $270000.0 in Q3 2022 and troughed at $180000.0 in Q1 2021.
- A 3-year average of $225888.9 and a median of $235000.0 in 2021 frame the typical range for Depreciation and Depletion.
- The widest YoY moves for Depreciation and Depletion: up 40.0% in 2022, down 8.09% in 2022.
- Over 3 years, Depreciation and Depletion stood at $188000.0 in 2020, then climbed by 25.0% to $235000.0 in 2021, then climbed by 8.09% to $254000.0 in 2022.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $254000.0, $270000.0, and $259000.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 254,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Sep 30, 2022 | 270,000.00 |
| Sep 30, 2022 | 270,000.00 |
| Jun 30, 2022 | 259,000.00 |
| Jun 30, 2022 | 259,000.00 |
| Mar 31, 2022 | 249,000.00 |
| Mar 31, 2022 | 249,000.00 |
| Dec 31, 2021 | 235,000.00 |
| Dec 31, 2021 | 235,000.00 |
| Sep 30, 2021 | 213,000.00 |
| Sep 30, 2021 | 213,000.00 |
| Jun 30, 2021 | 185,000.00 |
| Jun 30, 2021 | 185,000.00 |
| Mar 31, 2021 | 180,000.00 |
| Mar 31, 2021 | 180,000.00 |
| Dec 31, 2020 | 188,000.00 |
| Dec 31, 2020 | 188,000.00 |